VF
KRON

Virtu Financial’s Kronos Bio KRON Stock Holding History

Virtu Financial’s Portfolio KRON Stock Details KRON Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-14,107
Closed -$14K – 1810
2024
Q3 		$14K Buy
+14,107
New +$15.6K ﹤0.01% 1162
2024
Q2 		– Sell
-54,592
Closed -$71K – 1613
2024
Q1 		$71K Buy
+54,592
New +$62.2K 0.01% 971
2023
Q1 		– Sell
-15,418
Closed -$25K – 1809
2022
Q4 		$25K Buy
+15,418
New +$35.5K ﹤0.01% 1216

Other funds holding KRON

VVA
Vida Ventures Advisors Boston, Massachusetts $29.4M AUM 93.58% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
AI
Alphabet Inc Mountain View, California $4.02B AUM 215.74% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
WCM
Wildcat Capital Management New York $229M AUM 132.65% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return
SL
Siren LLC Greenwich, Connecticut $3.61B AUM 203.3% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Virtu Financial's KRON Position: Q4 2024 in Review

Virtu Financial sold out of Kronos Bio (KRON) in Q4 2024, closing a stake of 14,107 shares — an estimated $14K sold.

Virtu Financial first reported a position in KRON in Q4 2022 and held it in 3 quarters. The position peaked at $71K in Q1 2024. 56 funds tracked by Wall St. Rank hold KRON as of Q4 2024.

  • Virtu Financial reported no remaining Kronos Bio position as of Q4 2024 after selling out during the quarter.
  • Virtu Financial sold 14,107 Kronos Bio shares in Q4 2024, an estimated $14K.
  • Virtu Financial first reported a position in Kronos Bio in Q4 2022 and held it in 3 quarters.
  • Virtu Financial's Kronos Bio position peaked at $71K in Q1 2024.
  • 56 funds tracked by Wall St. Rank held Kronos Bio as of Q4 2024.

Based on Virtu Financial's 13F filing for Q4 2024, filed 11 Feb 2025.